Clinical Trials Browser

Phase 3 × Lymphoma, T-Cell, Peripheral × Cyclophosphamide × Clear all

NCT07258680 2025-12-02

BrEto-TCL

Phase 3 Enrolling by invitation

Lymphoma, T-Cell, Peripheral

NCT06072131 2025-10-23

CRESCENDO

Phase 3 Recruiting

Lymphoma, T-Cell, Peripheral

NCT06947967 2025-09-15

Tucidinostat in Combination With CHOP in Newly Diagnosed Peripheral T-Cell Lymphoma With Follicular Helper of T Cell Phenotype

Phase 3 Recruiting

Lymphoma, T-Cell, Peripheral

NCT03952572 2019-05-16

Efficacy and Safety of CDOP vs CHOP for Newly Diagnosed Peripheral T-cell Lymphoma

Phase 3 Unknown

Lymphoma, T-Cell, Peripheral

NCT00646854 2019-03-01

ACT-1

Phase 3 Completed

Lymphoma, T-Cell, Lymphoma, T-Cell, Peripheral

NCT03553537 2018-06-12

Efficacy and Safety of Decitabine Plus CHOP vs CHOP in Patients With Untreated Peripheral T-Cell Lymphoma

Phase 3 Unknown

Lymphoma, T-Cell, Peripheral

NCT03023358 2017-01-18

Compared the Efficacy and Safety of CDOP Combined With Chidamide and CDOP in de Novo Peripheral T Cell Lymphoma Patients

Phase 3 Unknown

Lymphoma, T-Cell, Peripheral